rs901824
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002335.4(LRP5):c.4348+23T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0862 in 1,602,452 control chromosomes in the GnomAD database, including 6,438 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.098 ( 881 hom., cov: 33)
Exomes 𝑓: 0.085 ( 5557 hom. )
Consequence
LRP5
NM_002335.4 intron
NM_002335.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.60
Publications
17 publications found
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
LRP5 Gene-Disease associations (from GenCC):
- bone mineral density quantitative trait locus 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- exudative vitreoretinopathy 4Inheritance: AD, SD, Unknown Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
- inherited retinal dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- osteoporosis-pseudoglioma syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal dominant osteosclerosis, Worth typeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- polycystic liver disease 4 with or without kidney cystsInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal dominant osteopetrosis 1Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- exudative vitreoretinopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyperostosis corticalis generalisataInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- osteosclerosis-developmental delay-craniosynostosis syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- polycystic liver disease 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 11-68438705-T-C is Benign according to our data. Variant chr11-68438705-T-C is described in ClinVar as Benign. ClinVar VariationId is 1263486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.145 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LRP5 | ENST00000294304.12 | c.4348+23T>C | intron_variant | Intron 20 of 22 | 1 | NM_002335.4 | ENSP00000294304.6 | |||
| LRP5 | ENST00000529993.5 | n.*2954+23T>C | intron_variant | Intron 20 of 22 | 1 | ENSP00000436652.1 | ||||
| LRP5 | ENST00000533695.1 | n.90+23T>C | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0982 AC: 14944AN: 152176Hom.: 880 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
14944
AN:
152176
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0749 AC: 18122AN: 242098 AF XY: 0.0740 show subpopulations
GnomAD2 exomes
AF:
AC:
18122
AN:
242098
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0849 AC: 123106AN: 1450158Hom.: 5557 Cov.: 30 AF XY: 0.0835 AC XY: 60256AN XY: 721952 show subpopulations
GnomAD4 exome
AF:
AC:
123106
AN:
1450158
Hom.:
Cov.:
30
AF XY:
AC XY:
60256
AN XY:
721952
show subpopulations
African (AFR)
AF:
AC:
5114
AN:
33340
American (AMR)
AF:
AC:
2593
AN:
44620
Ashkenazi Jewish (ASJ)
AF:
AC:
2329
AN:
26062
East Asian (EAS)
AF:
AC:
1806
AN:
39650
South Asian (SAS)
AF:
AC:
3398
AN:
86084
European-Finnish (FIN)
AF:
AC:
2366
AN:
48272
Middle Eastern (MID)
AF:
AC:
754
AN:
5598
European-Non Finnish (NFE)
AF:
AC:
99259
AN:
1106414
Other (OTH)
AF:
AC:
5487
AN:
60118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
6161
12323
18484
24646
30807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3640
7280
10920
14560
18200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0982 AC: 14956AN: 152294Hom.: 881 Cov.: 33 AF XY: 0.0949 AC XY: 7068AN XY: 74464 show subpopulations
GnomAD4 genome
AF:
AC:
14956
AN:
152294
Hom.:
Cov.:
33
AF XY:
AC XY:
7068
AN XY:
74464
show subpopulations
African (AFR)
AF:
AC:
6159
AN:
41550
American (AMR)
AF:
AC:
1135
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
319
AN:
3472
East Asian (EAS)
AF:
AC:
224
AN:
5178
South Asian (SAS)
AF:
AC:
217
AN:
4828
European-Finnish (FIN)
AF:
AC:
533
AN:
10622
Middle Eastern (MID)
AF:
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5908
AN:
68026
Other (OTH)
AF:
AC:
218
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
723
1446
2170
2893
3616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
263
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.